WO2026009009 - TRORILUZOLE HYDROCHLORIDE SALTS
National phase entry is expected:
Publication Number
WO/2026/009009
Publication Date
08.01.2026
International Application No.
PCT/HU2025/050045
International Filing Date
05.07.2025
Title **
[English]
TRORILUZOLE HYDROCHLORIDE SALTS
[French]
SELS DE CHLORHYDRATE DE TRORILUZOLE
Applicants **
EGIS GYÓGYSZERGYÁR ZRT.
Inventors
KIRÁLY, Imre
VIRÁG, Attila
SZEBELÉDI, Ildikó
SZUROMI, Veronika
Priority Data
P2400349
05.07.2024
HU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
|
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2904 | |
| EPO | Filing, Examination, Granting | 19474 | |
| Japan | Filing, Examination, Granting | 2614 | |
| South Korea | Filing, Examination, Granting | 2934 | |
| USA | Filing, Examination, Granting | 14130 |
Total:
42,056
Contact Us
Abstract[English]
Our invention relates to a process for the preparation of 2-amino-N-[2-[methyl-[2-oxo-2-[[6- (trifluoromethoxy)-1,3-benzothiazol-2-yl]amino]ethyl]amino]-2-oxoethyl]acetamide, to its new salts, its anhydrous forms, hydrates and solvates, to its new crystalline forms (in other words, polymorphic modifications or polymorphs), and to the preparation of all of these, to pharmaceutical compositions containing them, and to the medical applications of the new salts and crystalline forms according to the invention.[French]
La présente invention concerne un procédé de préparation de 2-amino-N-[2-[méthyl-[2-oxo-2-[[6-(trifluorométhoxy)-1,3-benzothiazol-2-yl]amino]éthyl]amino]-2-oxoéthyl]acétamide, ses nouveaux sels, ses formes anhydres, hydrates et solvats, ses nouvelles formes cristallines (en d'autres mots, des modifications polymorphes ou polymorphes), ainsi que leur préparation, les compositions pharmaceutiques les contenant, ainsi que les applications médicales des nouveaux sels et formes cristallines selon l'invention.